The study’s findings, corroborated by elevated IL-1β and IL-6 in AD patients with systemic infection, suggest that the AD brain is particularly vulnerable to intensified neuroinflammation during systemic inflammatory events, such as infection or injury, potentially accelerating disease progression. Here, IL6 is linked to Alzheimer disease.